PuraPharm Corp. Ltd. (HK:1498) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
PuraPharm Corp. Ltd. has announced a change in its auditor, replacing Ernst & Young with BDO Limited, due to more competitive proposals that promise enhanced corporate governance and cost-effectiveness. This shift follows EY’s resignation over a disagreement on audit fees for the upcoming fiscal year. The company assures that the transition will not impact its annual audit for FY2024.
For further insights into HK:1498 stock, check out TipRanks’ Stock Analysis page.